Legal Filings

Legal Filings
Jul 28, 2011

CREW Files FOIA with FDA for Records of Contact with Short Seller Martin Shkreli

Today, as part of a larger effort to ascertain the extent to which Wall Street investors are attempting to influence agency policy and regulation, CREW sent a Freedom of Information Act (FOIA) request to the Food and Drug Administration.  CREW’s request seeks records of all communications between FDA and Martin Shkreli, CEO of the hedge fund MSMB Capital Management.  Mr. Shkreli already has sought to influence the FDA’s drug approval process based on companies in which he held short positions. 

[ Please review our commenting policy here. ]  [ Comments powered by Disqus ]
© 2015 Citizens for Responsibility and Ethics in Washington, all rights reserved.
• 455 Massachusetts Avenue NW • Sixth Floor • Washington, DC 20001 • 202-408-5565 •


Citizens for Responsibility and Ethics in Washington®, and the
“CREW | Citizens for Responsibility and Ethics in Washington” wordmark are registered trademarks.